# Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis

> **NCT01050777** · EARLY_PHASE1 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 30 (estimated)

## Conditions studied

- Cutaneous Leishmaniasis

## Interventions

- **DRUG:** Liposomal meglumine antimoniate (Glucantime)
- **DRUG:** Liposomal meglumine antimoniate
- **DRUG:** Liposomal Paromomycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01050777
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-01
- **Final completion:** 2012-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2012-06-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01050777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01050777, "Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01050777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*